CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Signal vs Noise: Choosing the Right Antibody for Successful ChIP

Read More
All Posts

Part one of this series described the importance of including proper controls to your protocols. In Part 2, we discussed how chromatin preparation affects the final outcome of the experiment. Now, let's take a minute to consider the immunoprecipitating antibody.

Antibodies that are not highly specific to the target of interest may bind unpredictably and increase the background noise, and this may make it more difficult to detect less abundant or lower stability interactions.

How to Choose the Right Antibody for Successful ChIP

Your antibody should meet the following criteria.

It should be target-specific:

  • The antibody should demonstrate expected expression in positive/negative control cell lines, knockout cells, or siRNA-treated cells.
  • The antibody should show appropriate expression in response to enzyme-specific activators and/or inhibitors
  • The specificity of modification-specific histone antibodies should be verified using a peptide array or peptide ELISA.

It should have an acceptable signal-to-background ratio:

  • Signal-to-noise should be assessed using isotype controls.
  • The enrichment of known target genes should be at least 10-fold above background, as determined by real-time PCR analysis

The quality of the antibody isn’t the only factor that determines the outcome of the immunoprecipitation; the concentration of antibody can also dramatically affect your results. If the antibody concentration is too high, relative to the amount of chromatin, it may saturate the assay, leading to lower specific signal and/or increased background noise. Conversely, if the concentration of the antibody is too low it may fail to bind all of the target protein in the IP sample, resulting in less efficient immunoprecipitation.

ChIP-Validated Antibody from CST

ChIP-validated antibodies from CST are tested according to the criteria described above and each antibody is provided with a recommended starting concentration. But, if your antibody comes from another source you can use these guidelines to help ensure your antibody will work the way you expect it to.

Once the DNA is immunoprecipitated, it can be purified and you can move on to analyzing the results. That will be the focus of our next post, so until next time...


 

Additional Resources

Read our blog series on successful ChIP and ChIP-seq:

Check out our additional resources for chromatin profiling:

Carolyn P
Carolyn P
Carolyn is the director of Product Information & Digital Asset Management at CST.

Recent Posts

ELISA Kit Lot-to-Lot Reproducibility: Safeguard the Quality of Your Data

Over the past eight years working as a Product Scientist at CST, a big part of my role has been to test o...
Emily Estabrook Aug 27, 2025

Hallmarks of Cancer: Genome Instability and Mutation

Genetic alterations are a fundamental characteristic of cancer. When DNA mutations and chromosomal rearra...
Susan Keezer, PhD Aug 20, 2025

Hallmarks of Cancer: Avoiding Immune Destruction

This blog explores the mechanisms, pathways, and proteins involved in one of the Hallmarks of Cancer—Avoi...
Emily Alonzo, PhD Aug 13, 2025